Corteria Pharmaceuticals Employee Directory
Biotechnology ResearchÎle-de-france, France11-50 Employees
Corteria Pharmaceuticals is a Paris-based biotechnology company focused on developing therapies for deteriorating heart failure and acute decompensation episodes. Its work targets cardiovascular conditions where current treatments do not adequately serve certain patient subgroups. The company positions itself within biotechnology research, seeking to translate scientific insights into new therapeutic approaches for severe heart failure. Based in Paris, Île-de-France, the firm operates as a smaller, growing enterprise. In January 2024, Corteria named Dr. Mark Pruzanski as chairman of its board.